CTS received notification from Sanochemia Pharmazeutika AG of their intent to immediately discontinue production of Fluorognost HIV-1 IFA test kits routinely used for confirmation of HIV-1 antibody-reactive donations. Based on our current testing volume, CTS has sufficient HIV-1 IFA reagent inventory to continue performing this confirmatory test through the end of August 2019.
Check out the Communication page for the complete details on the updated IFA HIV-1 assay or by clicking the link: Communications
On June 13, 2019, CTS provided information regarding the manufacturer’s discontinuation of HIV...
The FDA Guidance ZIKV video for the webinar held on 08/15/18 has been posted in the Wh...
On September 23, 2019, the new CTS Laboratory Information System successfully implemented in Da...
On April 15, 2019, the New CTS Laboratory Information System has been successfully implemented in Po...
On May 9, 2019 the Food and Drug Administration issued a “Recommendations for Reducing the Ris...
Daylight Saving Time Begins March 10, 2019. As a friendly reminder, airlines often change their rout...